[EN] BENZAMIDE DERIVATIVE USEFUL AS FASN INHIBITORS FOR THE TREATMENT OF CANCER [FR] DÉRIVÉ DE BENZAMIDE UTILE EN TANT QU'INHIBITEUR DE FAS POUR LE TRAITEMENT DU CANCER
[EN] BENZAMIDE DERIVATIVE USEFUL AS FASN INHIBITORS FOR THE TREATMENT OF CANCER [FR] DÉRIVÉ DE BENZAMIDE UTILE EN TANT QU'INHIBITEUR DE FAS POUR LE TRAITEMENT DU CANCER
BENZAMIDE DERIVATIVE USEFUL AS FASN INHIBITORS FOR THE TREATMENT OF CANCER
申请人:Janssen Pharmaceutica NV
公开号:US20160009688A1
公开(公告)日:2016-01-14
The present invention is directed to benzamide derivatives, pharmaceutical compositions containing them, and their use as FASN inhibitors, in for example, the treatment of cancer, obesity related disorders, liver related disorders and viral infections. Such compounds are represented by formula (I) as follows:
wherein R
1
, R
2
, R
3
, R
4
, R
5
, m, n,
are defined herein.
[EN] BISAMLDE DERIVATIVES AND USE THEREOF AS FATTY ACID SYNTHASE INHIBITORS<br/>[FR] DÉRIVÉS DE BISAMIDE ET UTILISATION DE CEUX-CI EN TANT QU'INHIBITEURS DE L'ACIDE GRAS SYNTHASE
申请人:ASTRAZENECA AB
公开号:WO2008059214A1
公开(公告)日:2008-05-22
[EN] A compound of formula I, or a pharmaceutically acceptable salt thereof, processes for preparing such compounds, their use as Fatty Acid Synthase inhibitors, methods for their therapeutic use, particularly in the treatment of obesity and diabetes mellitus, and pharmaceutical compositions containing them. [FR] La présente invention a trait à un composé de formule I, ou à un sel, acceptable sur le plan pharmaceutique, de celui-ci, à des procédés de préparation desdits composés, à leur utilisation en tant qu'inhibiteurs de l'acide gras synthase, à des procédés d'utilisation thérapeutique de ceux-ci, en particulier dans le traitement de l'obésité et du diabète sucré, et à des compositions pharmaceutiques en contenant.
[EN] BENZAMIDE DERIVATIVE USEFUL AS FASN INHIBITORS FOR THE TREATMENT OF CANCER<br/>[FR] DÉRIVÉ DE BENZAMIDE UTILE EN TANT QU'INHIBITEUR DE FAS POUR LE TRAITEMENT DU CANCER
申请人:JANSSEN PHARMACEUTICA NV
公开号:WO2015084606A1
公开(公告)日:2015-06-11
The present invention is directed to benzamide derivatives, pharmaceutical compositions containing them, and their use as FASN inhibitors, in for example, the treatment of cancer, obesity related disorders, liver related disorders and viral infections. Such compounds are represented by formula (I) as follows: wherein R1, R2, R3, R4, R5, m, n, (II) and (III) are defined herein.